Kyowa Kirin moo-ves out of transgenic cows as it offloads Hematech
This article was originally published in Scrip
Executive Summary
Some seven and a half years after the US firm was acquired to bolster Kirin Brewery's antibody production capabilities, Kyowa Hakko Kirin has divested its Hematech subsidiary to a US healthcare group.